Literature DB >> 2217011

Analgesic nitrous oxide for alcohol withdrawal: a critical appraisal after 10 years' use.

M A Gillman1, F J Lichtigfeld.   

Abstract

We describe a method of treating the mild to moderate alcohol withdrawal state which has been used successfully for 10 years in over 7,000 cases. It is now the standard therapy at the largest dedicated alcoholic rehabilitation centre in Southern Africa. The technique uses analgesic (subanaesthetic) concentrations of nitrous oxide, which in most cases is administered on a single occasion for 20 minutes only. This results in the most rapid detoxification presently available, such that within an hour of the commencement of therapy the patient is so improved that they can eat the next ward meal. Provided the correct equipment and simple training is used this non-anaesthetic treatment is completely free of any serious side effects and the patient is at all times conscious and cooperative. Apart from this the amounts of sedative medication, such as benzodiazepines, are drastically reduced during detoxification. Because of the rapidity of the therapeutic response this technique is useful also as a screening test for assessing those patients requiring intensive therapy for the alcohol withdrawal state. There is evidence of the usefulness of analgesic nitrous oxide therapy for treating other addictive withdrawal states including opioid and nicotine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2217011      PMCID: PMC2429646          DOI: 10.1136/pgmj.66.777.543

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  15 in total

Review 1.  Analgesic (sub anesthetic) nitrous oxide interacts with the endogenous opioid system: a review of the evidence.

Authors:  M A Gillman
Journal:  Life Sci       Date:  1986-10-06       Impact factor: 5.037

2.  Minimal sedation required with nitrous oxide-oxygen treatment of the alcohol withdrawal state.

Authors:  M A Gillman; F J Lichtigfeld
Journal:  Br J Psychiatry       Date:  1986-05       Impact factor: 9.319

Review 3.  Haematological changes caused by nitrous oxide. Cause for concern?

Authors:  M A Gillman
Journal:  Br J Anaesth       Date:  1987-02       Impact factor: 9.166

4.  Treatment of alcoholism.

Authors:  G L Klerman
Journal:  N Engl J Med       Date:  1989-02-09       Impact factor: 91.245

5.  Analgesic nitrous oxide for addictive withdrawal states.

Authors:  M A Gillman
Journal:  S Afr Med J       Date:  1989-02-04

Review 6.  Receptor hypothesis of the alcohol withdrawal state.

Authors:  M A Gillman; F J Lichtigfeld
Journal:  Adv Biochem Psychopharmacol       Date:  1983

7.  [3H]naloxone displacement: evidence for nitrous oxide as opioid receptor agonist.

Authors:  C Daras; R C Cantrill; M A Gillman
Journal:  Eur J Pharmacol       Date:  1983-04-22       Impact factor: 4.432

8.  The need for a clearer distinction between anesthesia and analgesia in relation to the opiate system.

Authors:  M A Gillman; D S Footerman
Journal:  Anesthesiology       Date:  1981-06       Impact factor: 7.892

Review 9.  Nitrous oxide, an opioid addictive agent. Review of the evidence.

Authors:  M A Gillman
Journal:  Am J Med       Date:  1986-07       Impact factor: 4.965

10.  The treatment of alcoholic withdrawal states with oxygen and nitrous oxide.

Authors:  F J Lichtigfeld; M A Gillman
Journal:  S Afr Med J       Date:  1982-03-06
View more
  4 in total

1.  Advances in understanding alcohol withdrawal states.

Authors:  F J Lichtigfeld; M A Gillman
Journal:  Postgrad Med J       Date:  1991-07       Impact factor: 2.401

Review 2.  The drug management of severe alcohol withdrawal syndrome.

Authors:  M A Gillman; F J Lichtigfeld
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

3.  Analgesic nitrous oxide: rapid, safe therapy for addictive withdrawal.

Authors:  R Ojutkangas
Journal:  Postgrad Med J       Date:  1991-11       Impact factor: 2.401

4.  Nitrous oxide at homeopathic doses.

Authors:  M A Gillman
Journal:  J R Soc Med       Date:  1993-05       Impact factor: 5.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.